Northumbria University
Newcastle upon Tyne, Tyne on Wear, NE1 8ST, United Kingdom
NCT Number: NCT01682343
The purpose of this study is to investigate the appetite, insulin and incretin hormone responses to a high-calcium meal.
Looking for future studies?
Notify MeMale
Interventional
Not applicable
Newcastle upon Tyne, Tyne on Wear, NE1 8ST, United Kingdom
Participants will be provided with control and high-calcium meals. Insulin, appetite, glucagon-like peptide-1 and glucose-dependent insulinotropic peptide responses will be assessed, along with rates of substrate oxidation.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Milk-calcium supplement
Time frame: 3 hour
Subjective ratings of appetite assessed by visual analogue scales.
Time frame: 2 hour
2 hour area under the curve for serum insulin following breakfast consumption
Time frame: 2 hour
2 hour area under the curve for plasma glucose-dependent insulinotropic peptide following breakfast consumption
Time frame: 2 hour
2 hour area under the curve for plasma glucagon-like peptide-1 following breakfast consumption
Time frame: 1 hour
Assessed by indirect calorimetry
Northumbria University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06127823
Diabetes Mellitus, Diabetes, Gestational
Herlev, Denmark
View Trial DetailsNCT04451499
Bariatric Surgery Candidate, Nutritional and Metabolic Diseases
Tel Aviv, Israel
View Trial DetailsNCT07194577
Diabetes Mellitus, Diabetes Mellitus, Type 2
Colima, Centro, Mexico
View Trial DetailsNCT04700436
Diabetes Mellitus, Diabetes Mellitus, Type 2
Ansan, South Korea
View Trial Details